Drew Hope

Another day, another headline story for MAXWELLIA. This week the Chemist+Druggist report how MAXWELLIA is positioned as a 'switching machine,' as we continue to focus on the reclassification of medicines to improve self care. Read the featured story for insights from our CEO Anna Maxwell, including the future role of over-the-counter medicines. You'll find the link in the comments. #OTC #overthecounter #selfcare #NHS #switching #femalefounder #buywomenbuilt

21

2 Comments

Rapid, detailed cell analysis technology soon ready to assess the difference it can make to process insights and timelines

11

The next chapter in RNA-based medicine What are RNA-therapeutics, and how will they revolutionise medicine? Julie Anderson answers these questions and tells us about CPI’s role in the industry. Read the blog from CPI here > https://bit.ly/4dFcjLo

1

From revolutionising treatment methods to reshaping the UK's real estate environment - delve into our latest report on the growing field of Cell & Gene Therapies (CGT). https://lnkd.in/gCQtqEk7 #RealEstateTrends #LifeSciences

4

"As we forge ahead, let us remember that the ultimate measure of our success lies in the impact we have on the lives of patients." Gene and therapy promises a bright future but embracing a patient-centric approach is key, reflects Dan Gibson, Head of Collaborations at the Cell and Gene Therapy Catapult, in this account of our recent event “Unveiling Gene Therapy: Transforming medical practice through ATMPs”. Read the blog 👇 #genetherapy #celltherapy #AMTPs #healthcareinnovation

8

1 Comment

🌍 🌎 🌏 Cell and Gene Therapy (CGT) landscape 📈 "With complexity and risk associated with each stage of assay development, our Advanced Therapy Medicinal Products (ATMP) best practice guidance offers a practical and phase-appropriate validation tool to help your cell and gene therapy programme succeed. Our ATMP guidance includes: - Application of Flow Cytometry - Vector Copy Number - Characterisation of the Capsid Particle Population for rAAV products - T Cell and NK Cell Characterisation Assays" Exciting publication from Medicines and Healthcare products Regulatory Agency. Jacqueline Barry leads on some really exciting work 🔊 This particularly vindicates the continued importance of developing a talented workforce. Flow Cytometry, qPCR / ddPCR and ELISA are some of the key pieces of equipment for the above assays 🥇 Ideas or requirements for training anyone? 😎 Cell and Gene Therapy Catapult, Ryan Smith, #regulatory, #assays, #skills, #communitybuilding

6

Interesting article by Cartherics’ COO, Dr Ian Nisbet published in pharmaphorum discussing the evolution of antibody-drug conjugates (ADCs) and what they can teach us about advancing cancer treatments. The article offers insights into the challenges and opportunities that lie ahead for ADCs and cell therapies, shedding light on lessons that may shape the cell therapy space. Read it here: https://lnkd.in/gMFKyz_3

21

1 Comment

Looking to the future at what lies ahead in #cancerresearch, our CSO, Stefano Gullà spoke with Megan Thomas at Drug Discovery World (DDW) to discuss how Artificial Intelligence🖥will play an increasing role in both research and clinical development of next generation cancer treatments! Stefano commented 'With ongoing advances in technology, the landscape is poised for continued innovation and the development of transformative therapies that will improve patient outcomes and ultimately lead to better cancer prevention, diagnosis, and treatment strategies.' 📰 Find the Global Cancer Research Guide on page 40 in #DDW’s Summer issue 2024 here: https://bit.ly/3XGUYgl

20